| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 14% | -9.3% | $334,113,385 | -$31,963,105 | 13,766,518 | -8.7% | FMR LLC | 30 Sep 2025 |
| ARK Investment Management LLC | 10% | +30% | $223,401,540 | +$83,244,155 | 10,410,137 | +59% | ARK Investment Management LLC | 31 Jul 2025 |
| Farallon Capital Partners, L.P. | 10% | +0.9% | $196,567,436 | +$34,174,321 | 9,972,980 | +21% | Dapice Joshua J. | 31 Mar 2025 |
| BlackRock, Inc. | 7.5% | $147,823,620 | 7,499,930 | BlackRock, Inc. | 31 Mar 2025 | |||
| ARCH Venture Fund IX, L.P. | 4.6% | -17% | $90,680,723 | 4,600,747 | 0% | Robert Nelsen | 31 Mar 2025 |
As of 30 Sep 2025, 212 institutional investors reported holding 106,526,390 shares of Beam Therapeutics Inc. - COMMON STOCK (BEAM). This represents 105% of the company’s total 101,224,395 outstanding shares.
The largest institutional shareholders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) together control 94% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 12% | 11,692,853 | -9.8% | 0.01% | $283,785,536 |
| ARK Investment Management LLC | 11% | 11,038,834 | +25% | 1.6% | $267,912,511 |
| FARALLON CAPITAL MANAGEMENT LLC | 9.9% | 10,063,111 | +0.5% | 1.4% | $244,231,704 |
| VANGUARD GROUP INC | 9.1% | 9,250,784 | -4.7% | 0% | $224,516,528 |
| BlackRock, Inc. | 8% | 8,148,205 | +1.8% | 0% | $197,756,936 |
| Sumitomo Mitsui Trust Group, Inc. | 4.8% | 4,830,738 | +2.1% | 0.07% | $117,242,011 |
| Amova Asset Management Americas, Inc. | 4.8% | 4,830,738 | +2.2% | 1.1% | $117,242,011 |
| ARCH Venture Management, LLC | 4.5% | 4,540,132 | 0% | 22% | $110,189,004 |
| STATE STREET CORP | 4% | 4,008,658 | +10% | 0% | $97,290,130 |
| Bellevue Group AG | 2.9% | 2,889,288 | 0% | 1.5% | $70,123,020 |
| Kynam Capital Management, LP | 2.5% | 2,517,647 | +4.1% | 4.5% | $61,103,293 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 2,390,943 | +6.1% | 0% | $58,037,383 |
| MWG Management Ltd. | 2.2% | 2,266,934 | 0% | 68% | $55,018,488 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.2% | 2,263,149 | -7.4% | 0.01% | $54,928,000 |
| DIMENSIONAL FUND ADVISORS LP | 1.7% | 1,720,290 | -2.2% | 0.01% | $41,749,524 |
| UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC | 1.6% | 1,665,385 | +238% | 0.01% | $40,418,893 |
| Casdin Capital, LLC | 1.6% | 1,600,000 | +10% | 3.2% | $38,832,000 |
| Contrarius Group Holdings Ltd | 1.5% | 1,533,269 | 1.7% | $37,212,439 | |
| Redmile Group, LLC | 1.4% | 1,387,559 | -2.5% | 3.3% | $33,676,057 |
| GOLDMAN SACHS GROUP INC | 1.3% | 1,318,653 | +2.8% | 0% | $32,003,708 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1.2% | 1,260,011 | +11% | 0.1% | $30,580,467 |
| UBS Group AG | 1.1% | 1,137,633 | -2.3% | 0.01% | $27,610,353 |
| NORTHERN TRUST CORP | 0.84% | 854,344 | +3.1% | 0% | $20,734,929 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.83% | 841,210 | +8.6% | 0% | $20,416,167 |
| BANK OF AMERICA CORP /DE/ | 0.77% | 779,024 | -8.5% | 0% | $18,906,913 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 258,853 | $7,176,679 | +$3,921,759 | $27.72 | 20 |
| 2025 Q3 | 106,526,390 | $2,585,201,476 | -$9,455,165 | $24.27 | 212 |
| 2025 Q2 | 108,325,993 | $1,842,599,951 | +$102,159,924 | $17.01 | 213 |
| 2025 Q1 | 101,329,623 | $1,984,124,636 | +$387,248,348 | $19.53 | 234 |
| 2024 Q4 | 81,429,029 | $2,019,888,804 | +$52,922,730 | $24.80 | 228 |
| 2024 Q3 | 78,929,001 | $1,933,839,851 | +$32,128,779 | $24.50 | 217 |
| 2024 Q2 | 77,540,507 | $1,816,892,862 | +$138,460,483 | $23.43 | 210 |
| 2024 Q1 | 70,332,894 | $2,323,064,829 | +$51,308,447 | $33.04 | 217 |
| 2023 Q4 | 68,925,790 | $1,876,215,663 | +$46,457,918 | $27.22 | 183 |
| 2023 Q3 | 67,439,160 | $1,621,864,483 | +$72,305,572 | $24.05 | 190 |
| 2023 Q2 | 64,198,552 | $2,049,551,170 | +$123,991,732 | $31.93 | 191 |
| 2023 Q1 | 60,372,846 | $1,848,161,788 | +$134,989,244 | $30.62 | 205 |
| 2022 Q4 | 55,910,182 | $2,186,652,051 | +$42,258,811 | $39.11 | 205 |
| 2022 Q3 | 54,633,598 | $2,601,918,929 | -$6,231,369 | $47.64 | 214 |
| 2022 Q2 | 54,764,598 | $2,088,902,541 | +$192,782,034 | $38.71 | 191 |
| 2022 Q1 | 49,225,196 | $2,820,671,022 | +$201,996,007 | $57.30 | 230 |
| 2021 Q4 | 45,547,893 | $3,629,719,477 | -$39,454,291 | $79.69 | 224 |
| 2021 Q3 | 45,176,306 | $3,933,867,577 | -$43,842,015 | $87.01 | 223 |
| 2021 Q2 | 45,484,033 | $5,854,372,685 | +$342,578,385 | $128.71 | 223 |
| 2021 Q1 | 43,012,900 | $3,436,702,468 | +$478,571,473 | $80.04 | 203 |
| 2020 Q4 | 36,917,618 | $3,014,269,128 | +$632,622,766 | $81.64 | 152 |
| 2020 Q3 | 29,525,955 | $726,945,347 | +$39,624,702 | $24.62 | 84 |
| 2020 Q2 | 27,707,853 | $775,554,484 | +$34,103,632 | $28.00 | 70 |
| 2020 Q1 | 26,888,544 | $483,990,454 | +$483,990,450 | $18.00 | 60 |